Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA474328
Max Phase: Preclinical
Molecular Formula: C17H18N4O3S
Molecular Weight: 358.42
Molecule Type: Small molecule
Associated Items:
ID: ALA474328
Max Phase: Preclinical
Molecular Formula: C17H18N4O3S
Molecular Weight: 358.42
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=c1[nH]cnc2c([C@@H]3N[C@H](CSc4ccccc4)[C@@H](O)[C@H]3O)c[nH]c12
Standard InChI: InChI=1S/C17H18N4O3S/c22-15-11(7-25-9-4-2-1-3-5-9)21-13(16(15)23)10-6-18-14-12(10)19-8-20-17(14)24/h1-6,8,11,13,15-16,18,21-23H,7H2,(H,19,20,24)/t11-,13+,15-,16+/m1/s1
Standard InChI Key: RILVLBFFRDXSEY-JMGFVUJMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 358.42 | Molecular Weight (Monoisotopic): 358.1100 | AlogP: 0.78 | #Rotatable Bonds: 4 |
Polar Surface Area: 114.03 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 5 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.03 | CX Basic pKa: 8.14 | CX LogP: 0.05 | CX LogD: -0.68 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.44 | Np Likeness Score: 0.14 |
1. Murkin AS, Clinch K, Mason JM, Tyler PC, Schramm VL.. (2008) Immucillins in custom catalytic-site cavities., 18 (22): [PMID:18778937] [10.1016/j.bmcl.2008.08.047] |
2. (2016) Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase, |
Source(2):